{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:39:44Z","timestamp":1792795184016,"version":"4.5.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00423-015-1342-7","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T13:30:39Z","timestamp":1444311039000},"page":"867-886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":122,"title":["Hereditary hyperparathyroidism\u2014a consensus report of the European Society of Endocrine Surgeons (ESES)"],"prefix":"10.1007","volume":"400","author":[{"given":"Maurizio","family":"Iacobone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Carnaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Fausto","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno","family":"Vriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"issue":"7","key":"1342_CR1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1507\/endocrj.K09E-204","volume":"56","author":"F Tonelli","year":"2009","unstructured":"Tonelli F, Marcucci T, Giudici F, Falchetti A, Brandi ML (2009) Surgical approach in hereditary hyperparathyroidism. Endocr J 56(7):827\u201341","journal-title":"Endocr J"},{"issue":"10","key":"1342_CR2","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","volume":"99","author":"R Eastell","year":"2014","unstructured":"Eastell R, Brandi ML, Costa AG, D'Amour P, Shoback DM, Thakker RV (2014) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3570\u20139. doi: 10.1210\/jc.2014-1414","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1342_CR3","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.2014-2000","volume":"99","author":"R Udelsman","year":"2014","unstructured":"Udelsman R, Akerstr\u00f6m G, Biagini C, Duh QY, Miccoli P, Niederle B, Tonelli F (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99(10):3595\u2013606. doi: 10.1210\/jc.2014-2000","journal-title":"J Clin Endocrinol Metab"},{"key":"1342_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/01.sla.0000197334.58374.70","volume":"243","author":"S Heinrich","year":"2006","unstructured":"Heinrich S, Schafer M, Rousson V, Clavien PA (2006) Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 243:154\u201368","journal-title":"Ann Surg"},{"key":"1342_CR5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ, for the GRADE Working Group (2008) Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u20136","journal-title":"BMJ"},{"key":"1342_CR6","doi-asserted-by":"crossref","unstructured":"Lips CJ, Valk GD, Dreijerink KM, Timmers M, van der Luijt RB, Links T, van Nesselrooij BPM, Vriens MR, H\u00f6ppener JW, Borel Rinkes IHM (2015) Multiple Endocrine Neoplasia 1. In: Weiss, Retetoff (ed) Genetic Diagnosis on Endocrine Disorders, in press","DOI":"10.1016\/B978-0-12-800892-8.00024-5"},{"issue":"6","key":"1342_CR7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1406028","volume":"371","author":"KM Dreijerink","year":"2014","unstructured":"Dreijerink KM, Goudet P, Burgess JR, Valk GD, International Breast Cancer in MEN1 Study Group (2014) Breast-cancer predisposition in multiple endocrine neoplasia type 1. N Engl J Med 7 371(6):583\u2013584","journal-title":"N Engl J Med 7"},{"issue":"2","key":"1342_CR8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-12-0210","volume":"167","author":"JM Laat de","year":"2012","unstructured":"de Laat JM, Tham E, Pieterman CR, Vriens MR, Dorresteijn JA, Bots ML, Nordenskj\u00f6ld M, van der Luijt RB, Valk GD (2012) Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors. Eur J Endocrinol 167(2):181\u20137","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"1342_CR9","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). Endocrine Society. J Clin Endocrinol Metab 97(9):2990\u20133011","journal-title":"J Clin Endocrinol Metab"},{"key":"1342_CR10","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A et al (2001) Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658\u201371","journal-title":"J Clin Endocrinol Metab"},{"key":"1342_CR11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2362.2000.00664.x","volume":"30","author":"JF Roijers","year":"2000","unstructured":"Roijers JF, de Wit MJ, van der Luijt RB, Ploos van Amstel HK, H\u00f6ppener JW, Lips CJ (2000) Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding. Eur J Clin Invest 30:487\u201392","journal-title":"Eur J Clin Invest"},{"key":"1342_CR12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000658-198101000-00004","volume":"193","author":"RA Prinz","year":"1981","unstructured":"Prinz RA, Gamvros OI, Sellu D et al (1981) Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type 1 syndrome. Ann Surg 193:26\u20139","journal-title":"Ann Surg"},{"issue":"3","key":"1342_CR13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0002-9343(85)90340-7","volume":"78","author":"R Rizzoli","year":"1985","unstructured":"Rizzoli R, Green J 3rd, Marx SJ (1985) Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med 78(3):467\u201374","journal-title":"Am J Med"},{"issue":"4","key":"1342_CR14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/BF01655552","volume":"10","author":"J Malmaeus","year":"1986","unstructured":"Malmaeus J, Benson L, Johansson H, Ljunghall S, Rastad J, Akerstr\u00f6m G, Oberg K (1986) Parathyroid surgery in the multiple endocrine neoplasia type I syndrome: choice of surgical procedure. World J Surg 10(4):668\u201372","journal-title":"World J Surg"},{"key":"1342_CR15","first-page":"1031","volume":"114","author":"DS O\u2019Riordain","year":"1993","unstructured":"O\u2019Riordain DS, O\u2019 Brian T, Grant CS et al (1993) Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 and 2. Surgery 114:1031\u20139","journal-title":"Surgery"},{"issue":"112","key":"1342_CR16","first-page":"32","volume":"26","author":"P Cougard","year":"1994","unstructured":"Cougard P, Proye C (1994) Hyperparathyroidism and multiple endocrine neoplasia type 1 (MEN-1). Acta Chir Austriaca 26(112):32\u20135","journal-title":"Acta Chir Austriaca"},{"key":"1342_CR17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0039-6060(98)70040-6","volume":"124","author":"P Hellmann","year":"1998","unstructured":"Hellmann P, Skogseid B, Oberg K et al (1998) Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery 124:993\u20139","journal-title":"Surgery"},{"issue":"2","key":"1342_CR18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archsurg.133.2.126","volume":"133","author":"JR Burgess","year":"1998","unstructured":"Burgess JR, David R, Parameswaran V, Greenaway TM, Shepherd JJ (1998) The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg 133(2):126\u20139","journal-title":"Arch Surg"},{"key":"1342_CR19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/110241501750099294","volume":"167","author":"C Dotzenrath","year":"2001","unstructured":"Dotzenrath C, Cupisti K, Goretzki PE et al (2001) Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential? Eur J Surg 167:173\u20138","journal-title":"Eur J Surg"},{"key":"1342_CR20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1067\/msy.2002.128607","volume":"132","author":"LC Arnalsteen","year":"2002","unstructured":"Arnalsteen LC, Alesina PF, Quireux JL et al (2002) Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery 132:1119\u201325","journal-title":"Surgery"},{"key":"1342_CR21","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0039-6060(03)00406-9","volume":"134","author":"DM Elaraj","year":"2003","unstructured":"Elaraj DM, Skarulis MC, Libutti SK et al (2003) Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery 134:858\u201365","journal-title":"Surgery"},{"issue":"9","key":"1342_CR22","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s00104-004-0838-4","volume":"75","author":"P Langer","year":"2004","unstructured":"Langer P, Wild A, Schilling T, Nies C, Rothmund M, Bartsch DK (2004) Multiple endocrine neoplasia type 1. Surgical therapy of primary hyperparathyroidism. Chirurg 75(9):900\u20136","journal-title":"Chirurg"},{"issue":"4","key":"1342_CR23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archsurg.140.4.374","volume":"140","author":"LA Lambert","year":"2005","unstructured":"Lambert LA, Shapiro SE, Lee JE, Perrier ND, Truong M, Wallace MJ, Hoff AO, Gagel RF, Evans DB (2005) Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg 140(4):374\u201382","journal-title":"Arch Surg"},{"issue":"1","key":"1342_CR24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1245\/ASO.2006.12.009","volume":"13","author":"CH Lee","year":"2006","unstructured":"Lee CH, Tseng LM, Chen JY, Hsiao HY, Yang AH (2006) Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates. Ann Surg Oncol 13(1):103\u20139","journal-title":"Ann Surg Oncol"},{"key":"1342_CR25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/archsurg.141.3.235","volume":"141","author":"JGH Hubbard","year":"2006","unstructured":"Hubbard JGH, Sebag F, Maweja S et al (2006) Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg 141:235\u20139","journal-title":"Arch Surg"},{"key":"1342_CR26","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/SLA.0b013e31811f4467","volume":"246","author":"F Tonelli","year":"2007","unstructured":"Tonelli F, Marcucci T, Fratini G et al (2007) Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? Ann Surg 246:1075\u201382","journal-title":"Ann Surg"},{"key":"1342_CR27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","volume":"247","author":"JA Norton","year":"2008","unstructured":"Norton JA, Venzon DJ, Berna MJ et al (2008) Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. Ann Surg 247:501\u201310","journal-title":"Ann Surg"},{"issue":"6","key":"1342_CR28","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00268-010-0605-2","volume":"34","author":"MD Salmeron","year":"2010","unstructured":"Salmeron MD, Gonzalez JM, Sancho Insenser J, Goday A, Perez NM, Zambudio AR, Paricio PP, Serra AS (2010) Causes and treatment of recurrent hyperparathyroidism after subtotal parathyroidectomy in the presence of multiple endocrine neoplasia 1. World J Surg 34(6):1325\u201331","journal-title":"World J Surg"},{"issue":"10","key":"1342_CR29","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/bjs.7154","volume":"97","author":"J Waldmann","year":"2010","unstructured":"Waldmann J, L\u00f3pez CL, Langer P, Rothmund M, Bartsch DK (2010) Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. Br J Surg 97(10):1528\u201334","journal-title":"Br J Surg"},{"issue":"9","key":"1342_CR30","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","volume":"35","author":"JM Schreinemakers","year":"2011","unstructured":"Schreinemakers JM, Pieterman CR, Scholten A, Vriens MR, Valk GD, Rinkes IH (2011) The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg 35(9):1993\u20132005","journal-title":"World J Surg"},{"issue":"1","key":"1342_CR31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.surg.2013.03.004","volume":"154","author":"M Versnick","year":"2013","unstructured":"Versnick M, Popadich A, Sidhu S, Sywak M, Robinson B, Delbridge L (2013) Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1-primary hyperparathyroidism. Surgery 154(1):101\u20135","journal-title":"Surgery"},{"issue":"6","key":"1342_CR32","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.surg.2014.08.006","volume":"156","author":"TC Lairmore","year":"2014","unstructured":"Lairmore TC, Govednik CM, Quinn CE, Sigmond BR, Lee CY, Jupiter DC (2014) A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery 156(6):1326\u201334","journal-title":"Surgery"},{"key":"1342_CR33","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1007\/s00268-009-9924-6","volume":"33","author":"P St\u00e5lberg","year":"2009","unstructured":"St\u00e5lberg P, Carling T (2009) Familial parathyroid tumors: diagnosis and management. World J Surg 33:2234\u201343","journal-title":"World J Surg"},{"key":"1342_CR34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1750-1172-8-50","volume":"8","author":"BA Twigt","year":"2013","unstructured":"Twigt BA, Scholten A, Valk GD, Rinkes IH, Vriens MR (2013) Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up. Orphanet J Rare Dis 8:50","journal-title":"Orphanet J Rare Dis"},{"key":"1342_CR35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11864-006-0042-5","volume":"7","author":"LH VanderWalde","year":"2006","unstructured":"VanderWalde LH, Haigh PI (2006) Surgical approach to the patient with familial hyperparathyroidism. Curr Treat Options Oncol 7:326\u201333","journal-title":"Curr Treat Options Oncol"},{"key":"1342_CR36","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00268-001-0046-z","volume":"25","author":"P Goudet","year":"2001","unstructured":"Goudet P, Cougard P, Verg\u00e8s B et al (2001) Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D\u2019etude des N\u00e9oplasies Endocriniennes Multiples study group. World J Surg 25:886\u201390","journal-title":"World J Surg"},{"issue":"5","key":"1342_CR37","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00423-009-0529-1","volume":"394","author":"R Mihai","year":"2009","unstructured":"Mihai R, Barczynski M, Iacobone M, Sitges-Serra A (2009) Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations. Langenbecks Arch Surg 394(5):785\u201398","journal-title":"Langenbecks Arch Surg"},{"key":"1342_CR38","first-page":"1080","volume":"112","author":"JL Kraimps","year":"1992","unstructured":"Kraimps JL, Duh QY, Demeure M, Clark OH (1992) Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery 112:1080\u20136","journal-title":"Surgery"},{"issue":"6","key":"1342_CR39","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","volume":"255","author":"CR Pieterman","year":"2012","unstructured":"Pieterman CR, van Hulsteijn LT, den Heijer M, van der Luijt RB, Bonenkamp JJ, Hermus AR, Borel Rinkes IH, Vriens MR, Valk GD (2012) Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. DutchMEN1 Study Group. Ann Surg 255(6):1171\u20138","journal-title":"Ann Surg"},{"issue":"3","key":"1342_CR40","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10689-010-9320-2","volume":"9","author":"F Raue","year":"2010","unstructured":"Raue F, Frank-Raue K (2010) Update multiple endocrine neoplasia type 2. Fam Cancer 9(3):449\u201357","journal-title":"Fam Cancer"},{"issue":"1","key":"1342_CR41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jocd.2012.11.003","volume":"16","author":"F Giusti","year":"2013","unstructured":"Giusti F, Cavalli L, Cavalli T, Brandi ML (2013) Hereditary hyperparathyroidism syndromes. J Clin Densitom 16(1):69\u201374","journal-title":"J Clin Densitom"},{"issue":"7","key":"1342_CR42","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s002689900123","volume":"20","author":"JL Kraimps","year":"1996","unstructured":"Kraimps JL, Denizot A, Carnaille B, Henry JF, Proye C, Bacourt F, Sarfati E, Dupond JL, Maes B, Travagli JP, Boneu A, Roger P, Houdent C, Barbier J, Modigliani E (1996) Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs \u00e1 Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons. World J Surg 20(7):808\u201312","journal-title":"World J Surg"},{"issue":"4","key":"1342_CR43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2796.1995.tb01212.x","volume":"238","author":"F Raue","year":"1995","unstructured":"Raue F, Kraimps JL, Dralle H, Cougard P, Proye C, Frilling A, Limbert E, Llenas LF, Niederle B (1995) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med 238(4):369\u201373","journal-title":"J Intern Med"},{"issue":"6","key":"1342_CR44","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0039-6060(96)80042-0","volume":"120","author":"KK Herfarth","year":"1996","unstructured":"Herfarth KK, Bartsch D, Doherty GM, Wells SA Jr, Lairmore TC (1996) Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Surgery 120(6):966\u201373","journal-title":"Surgery"},{"issue":"6","key":"1342_CR45","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee NY, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah MH, Waguespack SG (2015) Revised American Thyroid Association Guidelines for the management of medullary thyroid carcinoma. The American Thyroid Association Guidelines task force on medullary thyroid carcinoma. Thyroid 25(6):567\u2013610","journal-title":"Thyroid"},{"issue":"4","key":"1342_CR46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.surg.2009.10.010","volume":"147","author":"S Borot","year":"2010","unstructured":"Borot S, Lapierre V, Carnaille B, Goudet P, Penfornis A (2010) Results of cryopreserved parathyroid autografts: a retrospective multicenter study. Surgery 147(4):529\u201335","journal-title":"Surgery"},{"key":"1342_CR47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","volume":"257","author":"KJ Bradley","year":"2005","unstructured":"Bradley KJ, Hobbs MR, Buley ID et al (2005) Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med 257:18\u201326","journal-title":"J Intern Med"},{"key":"1342_CR48","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.surg.2014.08.004","volume":"156","author":"A Mehta","year":"2014","unstructured":"Mehta A, Patel D, Rosenberg A, Boufraqech M, Ellis RJ, Nilubol N, Quezado MM, Marx SJ, Simonds WF, Kebebew E (2014) Hyperparathyroidism-jaw tumor syndrome: Results of operative management. Surgery 156:1315\u201325","journal-title":"Surgery"},{"key":"1342_CR49","first-page":"1006","volume":"108","author":"CE Jackson","year":"1990","unstructured":"Jackson CE, Norum RA, Boyd SB et al (1990) Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 108:1006\u201312","journal-title":"Surgery"},{"key":"1342_CR50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A et al (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676\u201380","journal-title":"Nat Genet"},{"key":"1342_CR51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1469-7580.2006.00657.x","volume":"209","author":"A Porzionato","year":"2006","unstructured":"Porzionato A, Macchi V, Barzon L et al (2006) Immunohistochemical assessment of parafibromin in mouse and human tissues. J Anat 209:817\u201327. doi: 10.1111\/j.1469-7580.2006.00657.x","journal-title":"J Anat"},{"issue":"5","key":"1342_CR52","doi-asserted-by":"crossref","first-page":"e97994","DOI":"10.1371\/journal.pone.0097994","volume":"9","author":"G Masi","year":"2014","unstructured":"Masi G, Iacobone M, Sinigaglia A, Mantelli B, Pennelli G, Castagliuolo I, Pal\u00f9 G, Barzon L (2014) Characterization of a new CDC73 missense mutation that impairs parafibromin expression and nucleolar localization. PLoS One 9(5):e97994","journal-title":"PLoS One"},{"key":"1342_CR53","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1677\/erc.1.01058","volume":"13","author":"C Juhlin","year":"2006","unstructured":"Juhlin C, Larsson C, Yakoleva T et al (2006) Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr-Relat Cancer 13:509\u201323. doi: 10.1677\/erc.1.01058","journal-title":"Endocr-Relat Cancer"},{"key":"1342_CR54","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2006.02460.x","volume":"64","author":"KJ Bradley","year":"2006","unstructured":"Bradley KJ, Cavaco BM, Bowl MR et al (2006) Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin Endocrinol (Oxf) 64:299\u2013306. doi: 10.1111\/j.1365-2265.2006.02460.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1342_CR55","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1677\/ERC-08-0066","volume":"15","author":"G Masi","year":"2008","unstructured":"Masi G, Barzon L, Iacobone M et al (2008) Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr-Relat Cancer 15:1115\u201326. doi: 10.1677\/ ERC-08-0066","journal-title":"Endocr-Relat Cancer"},{"key":"1342_CR56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2265.2006.02534.x","volume":"65","author":"N Mizusawa","year":"2006","unstructured":"Mizusawa N, Uchino S, Iwata T et al (2006) Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome. Clin Endocrinol (Oxf) 65:9\u201316","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1342_CR57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00104-005-1110-2","volume":"77","author":"O Gimm","year":"2006","unstructured":"Gimm O, Lorenz K, Nguyen Thanh P et al (2006) Das Famili\u00e4re Nebenschilddr\u00fcsenkarzinom. Indikation zur prophylaktischen Parathyreoidektomie? Chirurg 77:15\u201324. doi: 10.1007\/s00104- 005-1110-2","journal-title":"Chirurg"},{"key":"1342_CR58","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4158\/EP10337.RA","volume":"17","author":"AR Pichardo-Lowden","year":"2011","unstructured":"Pichardo-Lowden AR, Manni A, Saunders BD, Baker MJ (2011) Familial hyperparathyroidism due to a germline mutation of the CDC73 gene: implications for management and age-appropriate testing of relatives at risk. Endocr Pract 17:602\u20139","journal-title":"Endocr Pract"},{"key":"1342_CR59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jso.20152","volume":"88","author":"M Iacobone","year":"2004","unstructured":"Iacobone M, Lumachi F, Favia G (2004) Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J Surg Oncol 88:223\u20138. doi: 10.1002\/jso.20152","journal-title":"J Surg Oncol"},{"key":"1342_CR60","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1359\/jbmr.060702","volume":"21","author":"TG Kelly","year":"2006","unstructured":"Kelly TG, Shattuck TM, Reyes-Mugica M et al (2006) Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res 21:1666\u201371","journal-title":"J Bone Miner Res"},{"key":"1342_CR61","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, Valimaki S, Obara T et al (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722\u20139. doi: 10.1056\/NEJMoa031237","journal-title":"N Engl J Med"},{"key":"1342_CR62","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K et al (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40:657\u201363. doi: 10.1136\/jmg.40.9.657","journal-title":"J Med Genet"},{"key":"1342_CR63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jc.2003-030675","volume":"89","author":"WF Simonds","year":"2004","unstructured":"Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ (2004) Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89:96\u2013102","journal-title":"J Clin Endocrinol Metab"},{"key":"1342_CR64","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","volume":"89","author":"F Cetani","year":"2004","unstructured":"Cetani F, Pardi E, Borsari SL et al (2004) Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89:5583\u201391. doi: 10.1210\/jc.2004-0294","journal-title":"J Clin Endocrinol Metab"},{"key":"1342_CR65","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1136\/jmg.2003.012369","volume":"41","author":"A Villablanca","year":"2004","unstructured":"Villablanca A, Calender A, Forsberg L et al (2004) Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). J Med Genet 41:e32","journal-title":"J Med Genet"},{"key":"1342_CR66","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1210\/jc.2003-031016","volume":"89","author":"BM Cavaco","year":"2004","unstructured":"Cavaco BM, Guerra L, Bradley KJ et al (2004) Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. J Clin Endocrinol Metab 89:1747\u201352. doi: 10.1210\/jc.2003-031016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1342_CR67","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jpeds.2004.04.023","volume":"145","author":"VM Howell","year":"2004","unstructured":"Howell VM, Zori RT, Stalker HJ et al (2004) A molecular diagnosis of hyperparathyroidism-jaw tumor syndrome in an adolescent with recurrent kidney stones. J Pediatr 145(4):567","journal-title":"J Pediatr"},{"key":"1342_CR68","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1210\/jc.2004-0991","volume":"90","author":"SD Moon","year":"2005","unstructured":"Moon SD, Park JH, Kim EM et al (2005) A Novel IVS2-1G\u2009>\u2009A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 90:878\u201383","journal-title":"J Clin Endocrinol Metab"},{"key":"1342_CR69","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tripleo.2005.06.011","volume":"101","author":"MJ Aldred","year":"2006","unstructured":"Aldred MJ, Talacko AA, Savarirayan R et al (2006) Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:212\u20138","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"1342_CR70","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1210\/jc.2005-1239","volume":"91","author":"V Guarnieri","year":"2006","unstructured":"Guarnieri V, Scillitani A, Muscarella LA et al (2006) Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance. J Clin Endocrinol Metab 91:2827\u201332","journal-title":"J Clin Endocrinol Metab"},{"key":"1342_CR71","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijom.2006.08.007","volume":"36","author":"Y Yamashita","year":"2007","unstructured":"Yamashita Y, Akiyama T, Mizusawa N, Yoshimoto K, Goto M (2007) A case of hyperparathyroidism-jaw tumour syndrome found in the treatment of an ossifying fibroma in the maxillary bone. Int J Oral Maxillofac Surg 36:365\u20139","journal-title":"Int J Oral Maxillofac Surg"},{"key":"1342_CR72","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1677\/ERC-06-0092","volume":"14","author":"F Cetani","year":"2007","unstructured":"Cetani F, Pardi E, Ambrogini E et al (2007) Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation. Endocr Relat Cancer 14:493\u20139","journal-title":"Endocr Relat Cancer"},{"key":"1342_CR73","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","volume":"156","author":"F Cetani","year":"2007","unstructured":"Cetani F, Ambrogini E, Viacava P et al (2007) Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur J Endocrinol 156:547\u201354","journal-title":"Eur J Endocrinol"},{"key":"1342_CR74","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1055\/s-2007-982052","volume":"132","author":"F Raue","year":"2007","unstructured":"Raue F, Haag C, Frank-Raue K (2007) Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma. Dtsch Med Wochenschr 132:1459\u201362","journal-title":"Dtsch Med Wochenschr"},{"key":"1342_CR75","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/BF03346439","volume":"31","author":"F Cetani","year":"2008","unstructured":"Cetani F, Pardi E, Ambrogini E et al (2008) Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment. J Endocrinol Invest 31:900\u20134","journal-title":"J Endocrinol Invest"},{"key":"1342_CR76","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.surg.2007.12.012","volume":"143","author":"MS Sarquis","year":"2008","unstructured":"Sarquis MS, Silveira LG, Pimenta FJ et al (2008) Familial hyperparathyroidism: surgical outcome after 30 years of follow up in three families with germline HRPT2 mutations. Surgery 143:630\u201340. doi: 10.1016\/j.surg.2007.12.012","journal-title":"Surgery"},{"key":"1342_CR77","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.surg.2008.08.008","volume":"144","author":"V Guarnieri","year":"2008","unstructured":"Guarnieri V, Bisceglia M, Bonfitto N et al (2008) Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations (letter to the editor). Surgery 144:839\u201340. doi: 10.1016\/j.surg.2008.08.008","journal-title":"Surgery"},{"key":"1342_CR78","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","volume":"94","author":"VM Howell","year":"2009","unstructured":"Howell VM, Gill A, Clarkson A et al (2009) Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 94:434\u201341","journal-title":"J Clin Endocrinol Metab"},{"key":"1342_CR79","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1590\/S0004-27302008000800003","volume":"52","author":"LG Silveira","year":"2008","unstructured":"Silveira LG, Dias EP, Marinho BC, Gomez RS, De Marco L, Sarquis MS (2008) HRPT2-related familial isolated hyperparathyroidism: could molecular studies direct the surgical approach? Arq Bras Endocrinol Metabol 52:1211\u201320","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"2","key":"1342_CR80","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.joms.2008.07.015","volume":"67","author":"BP Schmidt","year":"2009","unstructured":"Schmidt BP, Bradrick JP, Gabali A (2009) Hyperparathyroidism-jaw tumor syndrome: a case report. J Oral Maxillofac Surg 67(2):423\u20137. doi: 10.1016\/j.joms.2008.07.015","journal-title":"J Oral Maxillofac Surg"},{"key":"1342_CR81","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ando.2009.09.004","volume":"71","author":"N Rekik","year":"2010","unstructured":"Rekik N, Ben Naceur B, Mnif M et al (2010) Hyperparathyroidism-jaw tumor syndrome: a case report. Ann Endocrinol (Paris) 71:121\u20136","journal-title":"Ann Endocrinol (Paris)"},{"key":"1342_CR82","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1677\/ERC-09-0272","volume":"17","author":"LM Panicker","year":"2010","unstructured":"Panicker LM, Zhang JH, Dagur PK, Gastinger MJ, Simonds WF (2010) Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome. Endocr Relat Cancer 17:513\u201324","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"1342_CR83","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.endonu.2010.04.002","volume":"57","author":"B Veiguela","year":"2010","unstructured":"Veiguela B, Isidro ML, Jorge S, Ruano B (2010) An uncommon cause of hypercalcemia: synchronous carcinoma of two parathyroids in the context of hyperparathyroidism-jaw tumor syndrome. Endocrinol Nutr 57(8):391\u20133. doi: 10.1016\/j.endonu.2010.04.002","journal-title":"Endocrinol Nutr"},{"key":"1342_CR84","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12022-011-9151-1","volume":"22","author":"BM Cavaco","year":"2011","unstructured":"Cavaco BM, Santos R, Felix A et al (2011) Identification of de novo germline mutations in the HRPT2 gene in two apparently sporadic cases with challenging parathyroid tumor diagnoses. Endocr Pathol 22:44\u201352","journal-title":"Endocr Pathol"},{"issue":"38","key":"1342_CR85","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1055\/s-0031-1286358","volume":"136","author":"L-BG Frank-Raue","year":"2011","unstructured":"Frank-Raue L-BG, Lorenz A, Rondot S, Haag C, Schulze E, B\u00fcchler M, Raue F (2011) Hereditary variants of primary hyperparathyroidism. MEN1, MEN2, HPT-JT, FHH, FIHPT. Dtsch Med Wochenschr 136(38):1889\u201394. doi: 10.1055\/s-0031-1286358","journal-title":"Dtsch Med Wochenschr"},{"issue":"11","key":"1342_CR86","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/gcc.20911","volume":"50","author":"A Casc\u00f3n","year":"2011","unstructured":"Casc\u00f3n A, Huarte-Mendicoa CV, Javier Leandro-Garc\u00eda L et al (2011) Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family. Genes Chromosom Cancer 50(11):922\u20139. doi: 10.1002\/gcc.20911","journal-title":"Genes Chromosom Cancer"},{"issue":"4","key":"1342_CR87","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10689-011-9466-6","volume":"10","author":"WK Siu","year":"2011","unstructured":"Siu WK, Law CY, Lam CW et al (2011) Novel nonsense CDC73 mutations in Chinese patients with parathyroid tumors. Fam Cancer 10(4):695\u20139. doi: 10.1007\/s10689-011-9466-6","journal-title":"Fam Cancer"},{"key":"1342_CR88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.2011.04184.x","volume":"76","author":"R Domingues","year":"2012","unstructured":"Domingues R, Tomaz RA, Martins C, Nunes C, Bugalho MJ, Cavaco BM (2012) Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism. Clin Endocrinol (Oxf) 76:33\u20138","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1342_CR89","first-page":"65","volume":"10","author":"A Guerrouani","year":"2013","unstructured":"Guerrouani A, Rzin A, El Khatib K (2013) Hyperparathyroidism-jaw tumour syndrome detected by aggressive generalized osteitis fibrosa cystica. Clin Cases Miner Bone Metab 10(1):65\u20137. doi: 10.11138\/ccmbm\/2013.10.1.065","journal-title":"Clin Cases Miner Bone Metab"},{"key":"1342_CR90","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","volume":"98","author":"L Bricaire","year":"2013","unstructured":"Bricaire L, Odou MF, Cardot-Bauters C et al (2013) Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. J Clin Endocrinol Metab 98:E403\u20138","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1342_CR91","doi-asserted-by":"crossref","first-page":"E175","DOI":"10.1002\/hed.22918","volume":"35","author":"MR Kutcher","year":"2013","unstructured":"Kutcher MR, Rigby MH, Bullock M, Trites J, Taylor SM, Hart RD (2013) Hyperparathyroidism-jaw tumor syndrome. Head Neck 35(6):E175\u20137. doi: 10.1002\/hed.22918","journal-title":"Head Neck"},{"issue":"3","key":"1342_CR92","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/BF03401311","volume":"12","author":"A Ghemigian","year":"2013","unstructured":"Ghemigian A, Ghemigian M, Popescu I et al (2013) Familial isolated primary hyperparathyroidism due to HRPT2 mutation. Hormones (Athens) 12(3):454\u201360","journal-title":"Hormones (Athens)"},{"issue":"6","key":"1342_CR93","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.4158\/EP13187.CR","volume":"19","author":"AG Abdulla","year":"2013","unstructured":"Abdulla AG, O'Leary EM, Isorena JP, Diaz MF, Yeh MW (2013) Recurrent hyperparathyroidism and a novel nonsense mutation in a patient with hyperparathyriodism-jaw tumor syndrome. Endocr Pract 19(6):e134\u20137. doi: 10.4158\/EP13187.CR","journal-title":"Endocr Pract"},{"issue":"12","key":"1342_CR94","doi-asserted-by":"crossref","first-page":"e82292","DOI":"10.1371\/journal.pone.0082292","volume":"8","author":"V Pazienza","year":"2013","unstructured":"Pazienza V, La Torre A, Baorda F et al (2013) Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene. PLoS One 8(12):e82292. doi: 10.1371\/journal.pone.0082292","journal-title":"PLoS One"},{"issue":"2","key":"1342_CR95","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/cen.12461","volume":"81","author":"J Kong","year":"2014","unstructured":"Kong J, Wang O, Nie M, Shi J, Hu Y, Jiang Y, Li M, Xia W, Meng X, Xing X (2014) Familial isolated primary hyperparathyroidism\/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese. Clin Endocrinol (Oxf) 81(2):222\u201330. doi: 10.1111\/cen.12461","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1342_CR96","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s13402-014-0187-3","volume":"37","author":"MG Chiofalo","year":"2014","unstructured":"Chiofalo MG, Sparaneo A, Chetta M et al (2014) A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome. Cell Oncol (Dordr) 37(4):281\u20138. doi: 10.1007\/s13402-014-0187-3","journal-title":"Cell Oncol (Dordr)"},{"issue":"9","key":"1342_CR97","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1210\/jc.2014-1481","volume":"99","author":"E Korpi-Hy\u00f6v\u00e4lti","year":"2014","unstructured":"Korpi-Hy\u00f6v\u00e4lti E, Cranston T, Ryh\u00e4nen E, Arola J, Aittom\u00e4ki K, Sane T, Thakker RV, Schalin-J\u00e4ntti C (2014) CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma. J Clin Endocrinol Metab 99(9):3044\u20138. doi: 10.1210\/jc.2014-1481","journal-title":"J Clin Endocrinol Metab"},{"key":"1342_CR98","first-page":"680876","volume":"2014","author":"C Sriphrapradang","year":"2014","unstructured":"Sriphrapradang C, Sornmayura P, Chanplakorn N, Trachoo O, Sae-Chew P, Aroonroch R (2014) Fine-needle aspiration cytology of parathyroid carcinoma mimic h\u00fcrthle cell thyroid neoplasm. Case Rep Endocrinol 2014:680876. doi: 10.1155\/2014\/680876","journal-title":"Case Rep Endocrinol"},{"key":"1342_CR99","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00423-009-0511-y","volume":"394","author":"M Iacobone","year":"2009","unstructured":"Iacobone M, Masi G, Barzon L et al (2009) Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Langenbecks Arch Surg 394:817\u201325","journal-title":"Langenbecks Arch Surg"},{"key":"1342_CR100","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.surg.2007.09.029","volume":"142","author":"M Iacobone","year":"2007","unstructured":"Iacobone M, Barzon L, Porzionato A et al (2007) Parafibromin expression, single-gland involvement and limited parathyroidectomy in familial isolated hyperparathyroidism. Surgery 142:984\u201391. doi: 10.1016\/j.surg.2007.09.029","journal-title":"Surgery"},{"key":"1342_CR101","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.surg.2008.06.027","volume":"145","author":"M Iacobone","year":"2009","unstructured":"Iacobone M, Barzon L, Porzionato A et al (2009) The extent of parathyroidectomy for HRPT2-related hyperparathyroidism. Surgery 145:250\u20131. doi: 10.1016\/j.surg.2008.06.027","journal-title":"Surgery"},{"key":"1342_CR102","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2796.2004.01428.x","volume":"257","author":"T Carling","year":"2005","unstructured":"Carling T, Udelsman R (2005) Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med 257:27\u201337","journal-title":"J Intern Med"},{"key":"1342_CR103","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00423-005-0555-6","volume":"390","author":"M Iacobone","year":"2005","unstructured":"Iacobone M, Ruffolo C, Lumachi F, Favia G (2005) Results of iterative surgery for persistent and recurrent parathyroid carcinoma. Langenbecks Arch Surg 390:385\u201390. doi: 10.1007\/s00423-005-0555-6","journal-title":"Langenbecks Arch Surg"},{"issue":"11","key":"1342_CR104","first-page":"3048","volume":"62","author":"A Fritz","year":"2002","unstructured":"Fritz A, Walch A, Piotrowska K, Rosemann M, Sch\u00e4ffer E, Weber K, Timper A, Wildner G, Graw J, H\u00f6fler H, Atkinson MJ (2002) Recessive transmission of a multiple endocrine neoplasia syndrome in the rat. Cancer Res 62(11):3048\u201351","journal-title":"Cancer Res"},{"key":"1342_CR105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0079-6123(10)82013-8","volume":"182","author":"S Molatore","year":"2010","unstructured":"Molatore S, Pellegata NS (2010) The MENX syndrome and p27: relationships with multiple endocrine neoplasia. Prog Brain Res 182:295\u2013320","journal-title":"Prog Brain Res"},{"issue":"42","key":"1342_CR106","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","volume":"103","author":"NS Pellegata","year":"2006","unstructured":"Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, H\u00f6fler H, Fend F, Graw J, Atkinson MJ (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci U S A 103(42):15558\u201363","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1-2","key":"1342_CR107","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","volume":"386","author":"RV Thakker","year":"2014","unstructured":"Thakker RV (2014) Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol 386(1-2):2\u201315","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"1342_CR108","doi-asserted-by":"crossref","first-page":"E1825","DOI":"10.1002\/humu.21354","volume":"31","author":"S Molatore","year":"2010","unstructured":"Molatore S, Marinoni I, Lee M, Pulz E, Ambrosio MR, Degli Uberti EC, Zatelli MC, Pellegata NS (2010) A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization. Hum Mutat 31(11):E1825\u201335","journal-title":"Hum Mutat"},{"issue":"1","key":"1342_CR109","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000320366","volume":"93","author":"I Marinoni","year":"2011","unstructured":"Marinoni I, Pellegata NS (2011) p27kip1: a new multiple endocrine neoplasia gene? Neuroendocrinology 93(1):19\u201328","journal-title":"Neuroendocrinology"},{"issue":"2","key":"1342_CR110","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-14-0080","volume":"171","author":"F Tonelli","year":"2014","unstructured":"Tonelli F, Giudici F, Giusti F, Marini F, Cianferotti L, Nesi G, Brandi ML (2014) A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome. Eur J Endocrinol 171(2):K7\u201317","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1342_CR111","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","volume":"92","author":"M Georgitsi","year":"2007","unstructured":"Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, M\u00e4kinen MJ, Tuppurainen K, Paschke R, Gimm O, Koch CA, G\u00fcndogdu S, Lucassen A, Tischkowitz M, Izatt L, Aylwin S, Bano G, Hodgson S, De Menis E, Launonen V, Vahteristo P, Aaltonen LA (2007) Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92(8):3321\u20135","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1342_CR112","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","volume":"94","author":"SK Agarwal","year":"2009","unstructured":"Agarwal SK, Mateo CM, Marx SJ (2009) Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J Clin Endocrinol Metab 94(5):1826\u201334. doi: 10.1210\/jc.2008-2083","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1342_CR113","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1210\/jc.2010-1338","volume":"96","author":"J Costa-Guda","year":"2011","unstructured":"Costa-Guda J, Marinoni I, Molatore S, Pellegata NS, Arnold A (2011) Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas. J Clin Endocrinol Metab 96(4):E701\u20136","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1342_CR114","doi-asserted-by":"crossref","first-page":"13","DOI":"10.6061\/clinics\/2012(Sup01)04","volume":"67","author":"NS Pellegata","year":"2012","unstructured":"Pellegata NS (2012) MENX and MEN4. Clinics 67(1):13\u20138","journal-title":"Clinics"},{"key":"1342_CR115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000345670","volume":"41","author":"M Lee","year":"2013","unstructured":"Lee M, Pellegata N (2013) Multiple endocrine neoplasia type 4. Front Horm Res 41:63\u201378","journal-title":"Front Horm Res"},{"key":"1342_CR116","first-page":"1485","volume":"77","author":"WS Wassif","year":"1993","unstructured":"Wassif WS, Moniz CF, Friedman E et al (1993) Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab 77:1485\u20139","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1342_CR117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","volume":"81","author":"WF Simonds","year":"2002","unstructured":"Simonds WF, James-Newton LA, Agarwal SK, Yang B, Skarulis MC, Hendy GN, Marx SJ (2002) Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 81(1):1\u201326","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1342_CR118","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jocd.2012.11.003","volume":"16","author":"F Giusti","year":"2013","unstructured":"Giusti F, Cavalli L, Cavalli T, Brandi ML (2013) Hereditary hyperparathyroidism syndromes. J Clin Densitom: Assessment Skelet Health 16(1):69\u201374","journal-title":"J Clin Densitom: Assessment Skelet Health"},{"key":"1342_CR119","first-page":"1752","volume":"85","author":"C Larsson","year":"2000","unstructured":"Larsson C (2000) Dissecting the genetics of hyperparathyroidism\u2014new clues from an old friend. J Clin Endocrinol Metab 85:1752\u20134","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1342_CR120","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.beem.2013.04.007","volume":"27","author":"FM Hannan","year":"2013","unstructured":"Hannan FM, Thakker RV (2013) Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism. Best Pract Res Clin Endocrinol Metab 27(3):359\u201371","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"1342_CR121","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-08-0440","volume":"159","author":"SE Christensen","year":"2008","unstructured":"Christensen SE, Nissen PH, Verstergaard P et al (2008) Plasma 25-hydroxyvitmain D, 1,25-dihydroxyvitmain D, and PTH in familial hypocalciuric hypercalcaemia (FHH) and primary hyperparathyroidism (PHPT). Eur J Endocrinol 159(6):719\u201327","journal-title":"Eur J Endocrinol"},{"key":"1342_CR122","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00223-011-9517-x","volume":"89","author":"T Isaksen","year":"2011","unstructured":"Isaksen T, Nielsen CS, Christensen SE et al (2011) Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study. Calcif Tissue Int 89:285\u201394","journal-title":"Calcif Tissue Int"},{"key":"1342_CR123","unstructured":"Calcium sensing receptor database. http:\/\/www.casrdb.mcgill.ca . Accessed 24 April 2015"},{"key":"1342_CR124","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.berh.2007.11.006","volume":"22","author":"OI Egbuna","year":"2008","unstructured":"Egbuna OI, Brown EM (2008) Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol 22:129\u201348","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"1342_CR125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4158\/EP10308.RA","volume":"17","author":"J Varghese","year":"2011","unstructured":"Varghese J, Rich T, Jimenez C (2011) Benign familial hypocalciuric hypercalcaemia. Endocr Pract 17(1):13\u20137","journal-title":"Endocr Pract"},{"issue":"5","key":"1342_CR126","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","volume":"69","author":"SE Christensen","year":"2008","unstructured":"Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Brixen K, Mosekilde L (2008) Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf) 69(5):713\u201320. doi: 10.1111\/j.1365-2265.2008.03259.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1342_CR127","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0002-9343(84)90852-0","volume":"76","author":"WM Law Jr","year":"1984","unstructured":"Law WM Jr, Carney JA, Heath H 3rd (1984) Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcaemia). Am J Med 76:1021\u20136","journal-title":"Am J Med"},{"key":"1342_CR128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0046-8177(81)80123-2","volume":"12","author":"U Thorgeirsson","year":"1981","unstructured":"Thorgeirsson U, Costa J, Marx SJ (1981) The parathyroid glands in familial hypocalciuric hypercalcemia. Hum Pathol 12:229\u201337","journal-title":"Hum Pathol"},{"key":"1342_CR129","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1210\/jc.2008-2484","volume":"94","author":"SA Lietman","year":"2009","unstructured":"Lietman SA, Tenenbaum-Rakover Y, Jap TS et al (2009) A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia. J Clin Endocrinol Metab 94:4372\u20139","journal-title":"J Clin Endocrinol Metab"},{"key":"1342_CR130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1258\/0004563042466802","volume":"41","author":"IR Gunn","year":"2004","unstructured":"Gunn IR, Gaffney D (2004) Clinical and laboratory features of calcium-sensing receptor disorders: a systematic review. Ann Clin Biochem 41:441\u201358","journal-title":"Ann Clin Biochem"},{"key":"1342_CR131","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2265.1999.00788.x","volume":"50","author":"S Pearce","year":"1999","unstructured":"Pearce S, Steinmann B (1999) Casting new light on the clinical spectrum of neonatal severe hyperparathyroidism. Clin Endocrinol (Oxf) 50:691\u20133","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1342_CR132","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00431-004-1491-0","volume":"163","author":"S Waller","year":"2004","unstructured":"Waller S, Kurzawinski T, Spitz L et al (2004) Neonatal severe hyperparathyroidism: genotype\/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr 163:589\u201394","journal-title":"Eur J Pediatr"},{"key":"1342_CR133","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI117062","volume":"93","author":"MR Pollak","year":"1994","unstructured":"Pollak MR, Chou YH, Marx SJ et al (1994) Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 93:1108\u201312","journal-title":"J Clin Invest"},{"key":"1342_CR134","doi-asserted-by":"crossref","first-page":"e812","DOI":"10.1542\/peds.2011-0128","volume":"129","author":"A Wilhelm-Bals","year":"2012","unstructured":"Wilhelm-Bals A, Parvex P, Magdelaine C, Girardin E (2012) Successful use of bisphosphonate and calcimimetic in neonatal severe primary hyperparathyroidism. Pediatrics 129:e812\u20136","journal-title":"Pediatrics"},{"issue":"5","key":"1342_CR135","first-page":"2042","volume":"85","author":"T Carling","year":"2000","unstructured":"Carling T, Szabo E, Bai M et al (2000) Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 85(5):2042\u20137","journal-title":"J Clin Endocrinol Metab"},{"key":"1342_CR136","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00268-009-0100-9","volume":"33","author":"G Akerstr\u00f6m","year":"2009","unstructured":"Akerstr\u00f6m G (2009) Symposium on evidence-based endocrine surgery (hyperparathyroidism). World J Surg 33:2219\u201323","journal-title":"World J Surg"},{"key":"1342_CR137","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12672-011-0100-8","volume":"3","author":"LF Starker","year":"2012","unstructured":"Starker LF, Akerstr\u00f6m T, Long WD, Delgado-Verdugo A, Donovan P, Udelsman R, Lifton RP, Carling T (2012) Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Horm Cancer 3:44\u201351","journal-title":"Horm Cancer"},{"issue":"6","key":"1342_CR138","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s00268-009-0388-5","volume":"34","author":"A Skandarajah","year":"2010","unstructured":"Skandarajah A, Barlier A, Morlet-Barlat N, Sebag F, Enjalbert A, Conte-Devolx B, Henry JF (2010) Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age? World J Surg 34(6):1294\u20138. doi: 10.1007\/s00268-009-0388-5","journal-title":"World J Surg"},{"key":"1342_CR139","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12672-013-0147-9","volume":"4","author":"J Costa-Guda","year":"2013","unstructured":"Costa-Guda J, Soong CP, Parekh VI, Agarwal SK, Arnold A (2013) Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in in sporadic parathyroid adenomas. Horm Cancer 4:301\u20137","journal-title":"Horm Cancer"},{"key":"1342_CR140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2796.2009.02105.x","volume":"266","author":"A Falchetti","year":"2009","unstructured":"Falchetti A, Marini F, Giusti F et al (2009) DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes. J Intern Med 266:69","journal-title":"J Intern Med"},{"issue":"2","key":"1342_CR141","first-page":"N37","volume":"17","author":"SJ Marx","year":"2002","unstructured":"Marx SJ, Simonds WF, Agarwal SK et al (2002) Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res 17(2):N37\u201343","journal-title":"J Bone Miner Res"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-015-1342-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-015-1342-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-015-1342-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T05:42:56Z","timestamp":1567230176000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-015-1342-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":141,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1342"],"URL":"https:\/\/doi.org\/10.1007\/s00423-015-1342-7","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]}}}